Development of mouse models for the study of chloropicrin and hydrogen fluoride ocular injury

Robert D Causey1, Jeffrey A Koenig1, Jeffrey J Autrey2

  • 1Research Division, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Harford County, Maryland.

Insights

Researchers developed mouse models for toxicant-induced ocular injury using chloropicrin (CP) and hydrogen fluoride (HF). These models are crucial for evaluating new therapies and understanding injury mechanisms in the eye.

Area of Science:

  • Toxicology
  • Ophthalmology
  • Chemical Injury

Background:

  • Chemical terrorism poses a significant threat, with the eye being particularly vulnerable to toxicant exposure.
  • Developing reliable models for ocular injury is essential for therapeutic research.

Purpose of the Study:

  • To create and characterize mouse models of toxicant-induced ocular injury.
  • To evaluate the potential of chloropicrin (CP) and hydrogen fluoride (HF) in inducing controlled ocular damage.
  • To establish a foundation for testing novel therapeutics and investigating injury mechanisms.

Main Methods:

  • Female BALB/c mice were exposed to controlled concentrations of chloropicrin (CP) or hydrogen fluoride (HF) vapor.
  • Ocular injury was assessed clinically and histopathologically up to 12 weeks post-exposure.
  • Corneal neovascularization, epithelial loss, and inflammatory cytokine levels were quantified.

Main Results:

  • A dose-dependent induction of corneal neovascularization was observed.
  • Acute epithelial necrosis and stromal edema were noted, resolving by 12 weeks.
  • Elevated corneal inflammatory cytokine concentrations peaked at 24 hours and returned to baseline by 14 days.

Conclusions:

  • The developed mouse models effectively replicate moderate ocular injuries from CP and HF exposure.
  • These models provide a valuable platform for evaluating therapeutic interventions for chemical-induced eye injuries.
  • Further research can utilize these models to elucidate the molecular pathways involved in ocular toxicant injury.

Related Concept Videos